Cardiovascular disease (CVD) is a major concern in public health globally, as well as in
China, and remarkable variations of resources available and health system performance have
been noted. Relatively limited information is available about how evidence-based therapies
are incorporated appropriately into routine clinical practice. In addition, little
information is available about the magnitude and quality of PCI, which has developed rapidly
during the past several decades. Practical and applied knowledge from large unselected
population is needed to guide practice and policy for quality improvement and cost reduction.
This study will enroll patients undergoing PCI after admission consecutively in 30 tertiary
hospitals scattered all over China. At study entry, participants will be interviewed during
their index hospitalization, to collect information about symptoms, functioning, quality of
life, and medical care. Demographic characteristics, medical history, clinical features,
diagnostic tests, medications, procedures, and in-hospital outcomes of patients will be
abstracted from medical records by well trained professional abstractors. And CAG imaging
will be reviewed by national and international expert panels. At 1 month, 6 month, and 12
month after discharge, participants will return to the clinic for follow up visits, a
face-to-face interview will be conducted to get information about clinical events, symptoms,
functioning, quality of life, and medical care during the recovery period. At 1-Month and
12-Month follow-up visit, blood and urine sample will be collected. Participants' blood
samples will be stored for future biologic and genetic studies. This study will examine
various real-life factors that may affect patients recovery after PCI, including patients'
characteristics and treatment measures. Practical guidelines, quality evaluative system, and
appropriateness criteria will be established based on the findings, to improve patients
outcomes in future finally.
